skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Good morning my question concerns cxi which I hold but in a 1.6% position compared to your 4.12% but in that sector I am looking at adding gsy as an alternative and to give diversity simply because you have recommended it as one of the top ten holds in one of the last questions. my concern with cxi is the volatility that it has had over the last two years. is there also another stock in your universe that could also be added to bring the total to the 4.12% position but with two to three stocks instead of one...thanks for the great service
Read Answer Asked by gene on February 13, 2017
Q: My Question is on the Transalta preferred shares. I have the series C preferred shares that are paying me 6.8% and with reset this June expect the yield will be about 6.7%. I see that the company decided NOT to go ahead with the proposed exchange of the preferred shares last Friday. Is this a good or bad sign?

How risky do you view the Transalta preferred shares in terms of ability to pay dividends and viability long term of the company?

Please feel free to publish.

Tony
Read Answer Asked by Antoine on February 13, 2017
Q: I currently have half positions in these energy co.s & would like to move to full positions but am waiting on the uncertainty with the US to settle. It also appears that the OPEC production cuts are actually occurring to some extent but that they are only for a 6 month period. Given the US uncertainty & the OPEC situation I am wondering what the impacts might be on Cdn energy stocks & your thoughts on when to move to full positions, or whether the expiry of the OPEC agreement might be negative for Cdn energy? As always, thanks for your insights.
Read Answer Asked by Brian on February 13, 2017
Q: Can you please comment or provide any opinion on ATE phase2 trials for their ATB-346 drug? my understanding is that results of liver tests in test patients have provided mixed results from the trials. Also please provide forecast for share price going forward based on potential drug trial success? I know they have been obtaining private funds and i believe GUD has 10 or 20% stake in ATE. thanks
Read Answer Asked by Gordon on February 13, 2017
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!